Agile Therapeutics, Inc. (AGRX)
OTCMKTS: AGRX · Delayed Price · USD
0.369
+0.001 (0.34%)
Apr 18, 2024, 2:09 PM EDT - Market open
Agile Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 2.56 | 5.25 | 19.14 | 14.46 | 34.48 | 7.85 | 35.95 | 48.75 | 34.4 | 40.18 | Upgrade
|
| Short-Term Investments | 0 | 0 | 0 | 40.01 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 2.56 | 5.25 | 19.14 | 54.47 | 34.48 | 7.85 | 35.95 | 48.75 | 34.4 | 40.18 | Upgrade
|
| Cash Growth | -51.26% | -72.60% | -64.86% | 57.98% | 339.17% | -78.16% | -26.25% | 41.74% | -14.40% | 1795.69% | Upgrade
|
| Receivables | 3.39 | 3.38 | 1.53 | 0.87 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Inventory | 2.74 | 1.33 | 0.97 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 0.84 | 1.4 | 2.28 | 1.45 | 0.84 | 0.61 | 0.76 | 2.77 | 3.69 | 0.8 | Upgrade
|
| Total Current Assets | 9.53 | 11.36 | 23.93 | 56.79 | 35.32 | 8.46 | 36.71 | 51.52 | 38.09 | 40.99 | Upgrade
|
| Property, Plant & Equipment | 0.49 | 0.87 | 13.4 | 14.38 | 14.04 | 13.92 | 13.86 | 12.33 | 12.32 | 12.05 | Upgrade
|
| Other Long-Term Assets | 0.24 | 2.01 | 2.01 | 1.9 | 0.18 | 0.02 | 0.02 | 0.02 | 0.31 | 1.79 | Upgrade
|
| Total Long-Term Assets | 0.73 | 2.88 | 15.41 | 16.28 | 14.22 | 13.93 | 13.88 | 12.35 | 12.63 | 13.84 | Upgrade
|
| Total Assets | 10.26 | 14.24 | 39.33 | 73.06 | 49.54 | 22.39 | 50.6 | 63.87 | 50.71 | 54.83 | Upgrade
|
| Accounts Payable | 9.57 | 7.73 | 8.71 | 3.87 | 1.82 | 2.22 | 2.78 | 5.4 | 5.04 | 3.69 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.85 | 0 | 0 | 0 | Upgrade
|
| Current Debt | 2.07 | 1.75 | 17.01 | 0.14 | 0.17 | 0 | 10.61 | 5.1 | 2.49 | 5 | Upgrade
|
| Other Current Liabilities | 9.13 | 3.91 | 3.56 | 3.35 | 1.8 | 0 | 0.03 | 0.17 | 0.41 | 0.3 | Upgrade
|
| Total Current Liabilities | 20.78 | 13.39 | 29.28 | 7.35 | 3.8 | 2.22 | 14.27 | 10.68 | 7.93 | 8.99 | Upgrade
|
| Long-Term Debt | 0.1 | 0.47 | 0.78 | 16.38 | 0 | 0 | 0 | 10.9 | 13.04 | 9.83 | Upgrade
|
| Other Long-Term Liabilities | 5.7 | 5.93 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Total Long-Term Liabilities | 5.8 | 6.4 | 0.78 | 16.38 | 0 | 0 | 0 | 10.9 | 13.04 | 9.83 | Upgrade
|
| Total Liabilities | 26.57 | 19.79 | 30.06 | 23.73 | 3.8 | 2.22 | 14.27 | 21.58 | 20.97 | 18.82 | Upgrade
|
| Total Debt | 2.17 | 2.21 | 17.79 | 16.52 | 0.17 | 0 | 10.61 | 16 | 15.52 | 14.83 | Upgrade
|
| Debt Growth | -1.76% | -87.57% | 7.71% | 9504.07% | - | - | -33.72% | 3.09% | 4.67% | -0.30% | Upgrade
|
| Common Stock | 0 | 0 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Retained Earnings | -423.17 | -408.7 | -387.12 | -312.22 | -260.37 | -241.55 | -221.77 | -193.47 | -164.73 | -134.39 | Upgrade
|
| Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -0.37 | -0.35 | -0.32 | -0.3 | -0.29 | Upgrade
|
| Shareholders' Equity | -16.32 | -5.55 | 9.27 | 49.33 | 45.75 | 20.17 | 36.32 | 42.29 | 29.74 | 36.01 | Upgrade
|
| Total Liabilities and Equity | 10.26 | 14.24 | 39.33 | 73.06 | 49.54 | 22.39 | 50.6 | 63.87 | 50.71 | 54.83 | Upgrade
|
| Net Cash / Debt | 0.39 | 3.04 | 1.35 | 37.95 | 34.31 | 7.85 | 25.35 | 32.75 | 18.87 | 25.35 | Upgrade
|
| Net Cash / Debt Growth | -87.31% | 124.65% | -96.44% | 10.62% | 336.98% | -69.02% | -22.60% | 73.52% | -25.56% | - | Upgrade
|
| Net Cash Per Share | 0.00 | 7.02 | 1113.39 | 896.34 | 1388.05 | 457.60 | 1638.33 | 2316.57 | 1714.39 | 4449.89 | Upgrade
|
| Working Capital | -11.25 | -2.03 | -5.35 | 49.43 | 31.52 | 6.24 | 22.44 | 40.84 | 30.15 | 31.99 | Upgrade
|
| Book Value Per Share | -0.01 | -12.83 | 7640.45 | 1165.02 | 1850.83 | 1175.85 | 2347.96 | 2991.58 | 2701.94 | 6320.17 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.